# Abbreviations and Definitions

## A

**ACN:** Acetonitrile

**AcOH:** Acetic acid

[**ADME(T)**](../methods-in-pharmacy/pre-formulation-and-formulation/biological-characterization/adme-t.md)**:** Absorption Distribution Metabolism Excretion (toxicity)

[**AFM**](../methods-in-pharmacy/analysis/microscopy/atomic-force-microscopy.md)**:** Atomic Force Microscopy

**API:** Active Pharmaceutical Ingredient

## B

**Biologic:** A drug product produced from or by a biological organism

**Biosimilar:** A biologic that is similar to another already approved reference biologic

[**BP**](../methods-in-pharmacy/pre-formulation-and-formulation/general-considerations.md#british-pharmacopoeia-bp)**:** British Pharmacopoeia

## C

[**CM**](../methods-in-pharmacy/analysis/microscopy/confocal-microscopy.md)**:** Confocal Microscopy

**CN:** Cyano

## D

[**DAD**](../methods-in-pharmacy/analysis/chromatography/methods-of-detection.md#diode-array)**:** Diode Array Detector

**DCM:** Dichloromethane

[**DLS**](../methods-in-pharmacy/analysis/particle-size-analysis/dynamic-light-scattering.md)**:** Dynamic Light Scattering

**DMF:**

* [Drug Master File](../methods-in-pharmacy/pre-formulation-and-formulation/general-considerations.md#drug-master-file)
* Dimethylformamide

**DMSO:** Dimethyl sulfoxide

**DRI:**

* [Degradation Related Impurity](../methods-in-pharmacy/pre-formulation-and-formulation/physiochemical-properties/purity.md#degradation-related-impurity-dri)
* [Differential Refractive Index](../methods-in-pharmacy/analysis/chromatography/methods-of-detection.md#refractive-index)

[**DSC**](../methods-in-pharmacy/analysis/physical-form/differential-scanning-calorimetry.md)**:** Differential Scanning Calorimetry

[**DVS**](../methods-in-pharmacy/analysis/hygroscopicity/dynamic-vapour-sorption.md)**:** Dynamic Vapour Sorption

## E

[**ECD**](../methods-in-pharmacy/analysis/chromatography/methods-of-detection.md#electrochemical)**:** Electrochemical Detector

**Efficacy:** Therapeutic effectiveness of a drug

[**ELSD**](../methods-in-pharmacy/analysis/chromatography/methods-of-detection.md#evaporative-light-scattering)**:** Evaporative Light Scattering Detector

**EM:**

* [Electromagnetic](../methods-in-pharmacy/analysis/spectroscopy/#electromagnetic-radiation)
* [Electron Microscopy](../methods-in-pharmacy/analysis/microscopy/electron-microscopy.md)

[**EP**](../methods-in-pharmacy/pre-formulation-and-formulation/general-considerations.md#european-pharmacopoeia-ep)**:** European Pharmacopoeia

[**ESI**](../methods-in-pharmacy/analysis/mass-spectrometry/ionization-methods.md#electrospray-esi)**:** Electrospray Ionization

**EtOH:** Ethanol

## F

**FDA:** Food and Drug Administration

[**FLD**](../methods-in-pharmacy/analysis/chromatography/methods-of-detection.md#fluorescence)**:** Fluorescence Detector

## G

[**GC**](../methods-in-pharmacy/analysis/chromatography/gas-chromatography/)**:** Gas Chromatography

[**GCP**](../methods-in-pharmacy/pre-formulation-and-formulation/general-considerations.md#good-clinical-practice-gcp)**:** Good Clinical Practice

[**GDP**](../methods-in-pharmacy/pre-formulation-and-formulation/general-considerations.md#good-documentation-practice-gdp)**:** Good Documentation Practice

**Generic:** A drug marketed under its chemical name

**GFC:** Gel Filtration Chromatography, see [Size Exclusion Chromatography](../methods-in-pharmacy/analysis/chromatography/methods-of-separation.md#size-exclusion)

[**GLP**](../methods-in-pharmacy/pre-formulation-and-formulation/general-considerations.md#good-laboratory-practice-glp)**:** Good Laboratory Practice

[**GMP**](../methods-in-pharmacy/pre-formulation-and-formulation/general-considerations.md#good-manufacturing-practice-gmp)**:** Good Manufacturing Practice

**GPC:** Gel Permeation Chromatography, see [Size Exclusion Chromatography](../methods-in-pharmacy/analysis/chromatography/methods-of-separation.md#size-exclusion)

[**GxP**](../methods-in-pharmacy/pre-formulation-and-formulation/general-considerations.md#good-practice-gxp)**:** Good Practice

## H

**HILIC:** Hydrophilic Interaction Chromatography

[**HPLC**](../methods-in-pharmacy/analysis/chromatography/high-performance-liquid-chromatography/)**:** High Performance Liquid Chromatography

**HTS:** High Throughput Screening

## I

**ICH:** International Conference on Harmonization

**ID:** Internal Diameter

[**IEC**](../methods-in-pharmacy/analysis/chromatography/methods-of-separation.md#ion-exchange)**:** Ion Exchange Chromatography

[**Impurity**](../methods-in-pharmacy/pre-formulation-and-formulation/physiochemical-properties/purity.md)**:** And part of a formulation/API that is not a defined component

**Inactive ingredient:** Any defined part of a formulation that is not an API

**IND:** Investigational New Drug

**Indications:** Treatments that a drug will address

_**in vitro:**_ Latin for "in glass", a process carried out outside a living organism

_**in vivo:**_ Latin for "in the body", a process carried out inside humans or animals

**IP:** Ion Pairing

**IPA:** Isopropyl Alcohol

**IMP**: Investigational Medicinal Product

**IR:** Infrared

[**IS**](../methods-in-pharmacy/basic-concepts/calibration.md#internal-standard)**:** Internal Standard

**ISO:** International Standards Organization

## J

[**JP**](../methods-in-pharmacy/pre-formulation-and-formulation/general-considerations.md#japanese-pharmacopoeia-jp)**:** Japanese Pharmacopoeia

## K

## L

**LC:** Liquid Chromatography

[**LCMS**](../methods-in-pharmacy/analysis/chromatography/methods-of-detection.md#mass-spec)**:** Liquid Chromatography Mass Spectrometry

[**LDA**](../methods-in-pharmacy/analysis/particle-size-analysis/laser-diffraction-analysis.md)**:** Laser Diffraction Analysis

**Ligand:** An agent with a high affinity for a substrate

**LIMS:** Laboratory Information Managements System

[**LM**](../methods-in-pharmacy/analysis/microscopy/light-microscopy.md)**:** Light Microscopy

**Lot:** Specific batch of a product with uniform character and quality

**LS:** Light Scattering

[**LoD**](../methods-in-pharmacy/basic-concepts/validation.md#limit-of-detection-lod)**:** Limit of Detection

[**LoQ**](../methods-in-pharmacy/basic-concepts/validation.md#limit-of-quantification-loq)**:** Limit of Quantification

## M

$$M_n$$**:** Number average molecular weight

$$M_V$$**:** Viscosity molecular weight

$$M_W$$**:** Weight average molecular weight

$$M_Z$$**:** Size average molecular weight

[**ME**](../methods-in-pharmacy/basic-concepts/calibration.md#matrix-effect)**:** Matrix Effect

**MeOH:** Methanol

**MS:** Mass Spectrometry

**MTBE:** Methyl t-Butyl Ether

## N

**NCE:** New Chemical Entity

**NDA:** New Drug Application

**NME:** New Molecular Entity

**NMP:** N-Methyl-2-pyrrolidone

[**NMR**](../methods-in-pharmacy/analysis/spectroscopy/nuclear-magnetic-resonance.md)**:** Nuclear Magnetic Resonance

[**NP**](../methods-in-pharmacy/analysis/chromatography/methods-of-separation.md#normal-phase)**:** Normal Phase

[**NTA**](../methods-in-pharmacy/analysis/particle-size-analysis/nanoparticle-tracking-analysis.md)**:** Nanoparticle Tracking Analysis

## O

**OD:** Outer Diameter

**ODS:** Octadecylsilane

**OTC:** Over the Counter, a drug which can be purchased without prescription

## P

[**PD**](../methods-in-pharmacy/pre-formulation-and-formulation/biological-characterization/pharmacodynamics-and-pharmacokinetics.md#pharmacodynamics)**:** Pharmacodynamics

**PDA:** Photodiode Array, see [Diode Array Detector](../methods-in-pharmacy/analysis/chromatography/methods-of-detection.md#diode-array)

[**PE**](../methods-in-pharmacy/basic-concepts/calibration.md#matrix-effect)**:** Process Efficiency

**PEEK:** Polyetherether ketone

[**pH**](../methods-in-pharmacy/pre-formulation-and-formulation/physiochemical-properties/pka.md#ph)**:** Parts Hydrogen

[**PK**](../methods-in-pharmacy/pre-formulation-and-formulation/biological-characterization/pharmacodynamics-and-pharmacokinetics.md#pharmacokinetics)**:** Pharmacokinetics

[**pKa**](../methods-in-pharmacy/pre-formulation-and-formulation/physiochemical-properties/pka.md#pka)**:** Acid Dissociation Constant

**Pilot scale:** Manufacture of an API at a reduced using processes representative of commercial scale production

**Placebo:** Inactive agent used comparatively to assess the efficacy of an API

**Polymorphism:** Different crystalline forms of the same compound

[**ppb**](../methods-in-pharmacy/basic-concepts/concentration.md#mass-fraction-parts-per)**:** Parts Per Billion

[**ppm**](../methods-in-pharmacy/basic-concepts/concentration.md#mass-fraction-parts-per)**:** Parts Per Million

[**PRI**](../methods-in-pharmacy/pre-formulation-and-formulation/physiochemical-properties/purity.md#process-related-impurity-pri)**:** Process Related Impurity

**psi:** Pounds Per Square Inch

**PTFE:** Poly(tetrafluoroethylene)

## Q

**QA:** Quality Assurance, activities performed to ensure required quality id obtained

**QC:** Quality Control

**QSAR:** Quantitative Structure Activity Relationship

## R

[**RE**](../methods-in-pharmacy/basic-concepts/calibration.md#matrix-effect)**:** Recovery from Extraction

**RI:** Refractive Index

[**RP**](../methods-in-pharmacy/analysis/chromatography/methods-of-separation.md#reversed-phase)**:** Reversed Phase

[**RSD**](../methods-in-pharmacy/basic-concepts/data-analysis.md#relative-standard-deviation)**:** Relative Standard Deviation

## S

**SAR:** Structure Activity Relationship

[**SAXS**](../methods-in-pharmacy/analysis/physical-form/small-angle-x-ray-scattering.md)**:** Small-angle X-ray Scattering

[**SEC**](../methods-in-pharmacy/analysis/chromatography/methods-of-separation.md#size-exclusion)**:** Size Exclusion Chromatography

**Small molecule:** A small chemically manufactured compound

[**SOP**](standard-operating-procedures.md)**:** Standard Operating Procedure

**SPE:** Solid Phase Extraction

**SST:** System Suitability Test

## T

**TEA:** Triethylamine

**TEAA:** Triethylamino acetate

**TFA:** Trifluoroacetic acid

[**TGA**](../methods-in-pharmacy/analysis/hygroscopicity/thermo-gravimetric-analysis.md)**:** Thermo Gravimetric Analysis

**THF:** Tetrahydrofuran

[**TLC**](../methods-in-pharmacy/analysis/chromatography/thin-layer-chromatography.md)**:** Thin Layer Chromatography

## U

**UHPLC:** Ultra High Pressure Liquid Chromatography

[**USP**](../methods-in-pharmacy/pre-formulation-and-formulation/general-considerations.md#united-states-pharmacopoeia-usp)**:** United States Pharmacopoeia

**UV:** Ultraviolet

## V

**Vis:** Visible

[**VWD**](../methods-in-pharmacy/analysis/chromatography/methods-of-detection.md#variable-wavelength)**:** Variable Wavelength Detector

## X

[**XRD**](../methods-in-pharmacy/analysis/physical-form/x-ray-diffraction.md)**:** X-ray Diffraction

## Y

## Z



